Volkmar Falk
Expertise in
29
conditions

Volkmar Falk

ETH Zurich
Zurich, ZH, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
29
conditions
ETH Zurich
Zurich, ZH, CH 
OverviewLocationsClinical Research

Overview

Volkmar Falk practices in Zurich, Switzerland. Falk is highly rated in 29 conditions, according to our data. Their top areas of expertise are Aortic Regurgitation, Aortic Valve Stenosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Heart Bypass Surgery.

Their clinical research consists of co-authoring 673 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

ETH Zurich
Zurich, ZH 8092, Switzerland
Other Locations
Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Enrollment Status: Recruiting
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy
Study Phase: Phase 3
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion
Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Procedure
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

673 Total Publications

Reply to Ankersmit et al.
Reply to Ankersmit et al.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Falk's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 14 Advanced Conditions
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile